That lack of regulation has hindered the growth trajectory of the industry and will continue to do so, industry members tell Cannabis Business Times, and data firm Brightfield Group stated in a July mid-year report. Food and Drug Administration (FDA) has not set forth regulations for the production, marketing and sale of CBD. In the nearly four years since the 2018 Farm Bill legalized hemp with a 0.3% THC limit in the U.S., the country’s CBD market has seen its fair share of ups and downs. 9, following state officials’ certification of 214,535 signatures, nearly 30,000 more than are required, CBT previously reported. Missouri Secretary of State Jay Ashcroft certified the measure Aug. The Missouri suit claimed the group behind the legalization initiative, Legal Missouri 2022, had not gathered enough valid voter signatures to put the measure on the ballot, and that the measure violates Missouri law and the state’s constitution, the AP reports. The SRA would federally decriminalize cannabis and defer power to state governments to regulate cannabis.
Nancy Mace, R-S.C., who introduced the States Reform Act (SRA), Cannabis Business Times previously reported. The same PAC is also attempting to unseat U.S. 19 with support from Protect Our Kids, a political action committee (PAC) formed by Luke Niforatos of Smart Approaches to Marijuana, according to the AP. Joy Sweeney, a resident of Jefferson City, Mo., filed the lawsuit Aug. Ninety-two percent of Americans support federal legalization of medical cannabis, and 67% of Americans support the legalization of adult-use cannabis, according to Digital Third Coast 19 states and Washington, D.C., have legalized adult-use cannabis and 39 states and Washington, D.C., have legalized medical cannabis for the treatment of various conditions, according to numerous government reports and CBT’s original reporting.Ī Missouri resident has filed a lawsuit to take an adult-use cannabis measure off the state’s November ballot, according to The Associated Press. The report does, however, note that cannabis is legal at state levels and “how it is talked about in the literature and society at large, is changing.” (While state adult-use cannabis programs require consumers to be at least 21 years old, age restrictions for medical cannabis programs vary by state and can include ages under 21, according to the Insurance Institute for Highway Safety.) Neither the MTF press release nor the report itself separate medical use from adult use of cannabis, nor do they acknowledge therapeutic benefits of cannabis. However, while not being quoted on how much she believes adult use of cannabis specifically is or isn’t a problem, Volkow indicated to the news outlet that some drugs that are used recreationally also have therapeutic benefits. Nora Volkow, director of the NIDA, told The New York Times the results indicate “the problem of substance abuse among young people has gotten worse in this country, and that the pandemic, with all its mental stressors and turmoil, has likely contributed to the rise.” “Prevalence of marijuana vaping in the past month among young adults had significantly dipped in 2020 but returned to near pre-pandemic levels in 2021,” according to an NIH press release.ĭr. The percentage of young adults surveyed who reported vaping cannabis in the past month was at 12% for 2021, double the 6% figure reported in 2017. Young adults who reported using cannabis daily (20 or more times in the past 30 days):
Young adults who reported using cannabis in the past month:
Young adults who reported cannabis use in the past year: The MTF started tracking young adult cannabis consumption for daily, past-month and past-year use in 1988, and the NIH has noted various upward consumption trends.
Funded by the NIH’s National Institute on Drug Abuse (NIDA), the MTF study is a survey conducted by the University of Michigan, and the results have been published since 1975, according to NIH. 22, the NIH announced this and other findings from the most recent Monitoring the Future (MTF) panel study, based on survey responses collected online between April and October 2021. National Institutes of Health (NIH) has found through a drug and alcohol use study. Cannabis use last year among young adults-19-30-year-olds-reached historic highs for the age group since 1988, the U.S.